Tuesday, February 07, 2017 11:38:40 AM
Commercializations plasminogen expected in 2017
California Capital Equity, LLC acquires 44 million ProMetic shares through the exercise of all outstanding warrants
PR Newswire PR NewswireFebruary 6, 2017
LAVAL, QC, Feb. 6, 2017 /PRNewswire/ - ProMetic Life Sciences Inc. (PLI.TO) (PFSCF) ("ProMetic" or the "Corporation") announced today that California Capital Equity, LLC, has exercised 44,791,488 share purchase warrants at a price of $0.47 per share for total proceeds of $21,051,999.36 to the Corporation.
"Our increased equity position in ProMetic represents a long term and strategic investment for us", said Dr. Patrick Soon-Shiong, Chief Executive Officer of California Capital Equity, LLC. "ProMetic has robust proprietary therapeutic platforms, promising growth potential and several plasma derived therapeutics expected to reach commercialization stages, starting in 2017 with plasminogen. We, through other investment vehicles, also have an on-going partnership with ProMetic in relation to IVIG and anticipate further collaborations going forward", added Dr. Soon-Shiong.
Recent LMNL News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 10/06/2023 12:30:57 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 09/27/2023 08:05:14 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/27/2023 04:15:20 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/26/2023 01:12:25 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 09/26/2023 01:08:22 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 09/26/2023 12:57:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/26/2023 12:55:25 PM
- Form SC 13E3/A - Going private transaction by certain issuers: [Amend] • Edgar (US Regulatory) • 09/26/2023 12:54:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/26/2023 12:16:58 PM
- LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP • PR Newswire (Canada) • 09/26/2023 12:00:00 PM
- LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP • PR Newswire (US) • 09/26/2023 12:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM